This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / AIM ImmunoTech Regains NYSE Compliance
Regulatory regulatory compliance

AIM ImmunoTech Regains NYSE Compliance

Analysis based on 6 articles · First reported Jun 15, 2026 · Last updated Jun 16, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is positively impacted by AIM ImmunoTech Inc.'s regained compliance with NYSE American listing standards, which removes uncertainty regarding its listing status. This action is likely to instill investor confidence and potentially stabilize or increase the company's stock price, as the 'below compliance' indicator is removed.

pharmaceuticals biotechnology
Event Summary

AIM ImmunoTech Inc., an immuno-pharma company, announced it has regained compliance with NYSE American's continued listing standards regarding stockholders' equity. The company had previously received a notice of non-compliance and had a '.BC' indicator on its trading symbol. To resolve this, AIM ImmunoTech Inc. undertook several financing activities, including a warrant exercise inducement offer on May 7, 2026, generating $3.5 million, and two private placements on May 21, 2026, and June 10, 2026, raising approximately $2.4 million and $2.6 million respectively. These transactions increased the company's stockholders' equity above the $6.0 million minimum requirement. On June 12, 2026, NYSE American formally confirmed the resolution of all deficiencies, leading to the removal of the '.BC' indicator and the company from the list of noncompliant issuers.

Entities Involved
stock
AIM ImmunoTech
AIM ImmunoTech Inc. regained compliance with NYSE American's listing standards, resolving its stockholders' equity deficiency through several financing transactions. This positive development removes the 'below compliance' indicator from its trading symbol and improves its market standing.
Importance 100.0 Sentiment 75.0
exch
NYSE American
NYSE American is the regulatory body that notified AIM ImmunoTech Inc. of its non-compliance and subsequently confirmed its regained compliance, thereby enforcing its listing standards.
Importance 80.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
Importance 0.0 Sentiment 0.0
Relationships
NYSE American related ↔ United States — United States Securities and Exchange Commission
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.